MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-04-2026
Smith & Nephew plc Revenue 2011-2026 | SNN
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Smith & Nephew plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 4.56 B | 5.14 B | 4.9 B | 4.76 B | 4.67 B | 4.63 B | 4.62 B | 4.35 B | 4.14 B | 4.27 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.14 B | 4.14 B | 4.6 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Medical devices industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
4 B | $ 186.66 | 1.07 % | $ 14 B |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
172 M | - | - | $ 1.77 B | USA |
 |
Helius Medical Technologies
HSDT
|
644 K | $ 1.99 | 0.25 % | $ 1.21 M | USA |
 |
Acutus Medical
AFIB
|
7.16 M | - | -26.83 % | $ 2.62 M | USA |
 |
Avinger
AVGR
|
7.65 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
274 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
12.3 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
3.24 B | $ 12.72 | -0.43 % | $ 1.72 B | USA |
 |
Allied Healthcare Products
AHPI
|
6.02 M | - | 3.58 % | $ 2.21 M | USA |
 |
Inogen
INGN
|
349 M | $ 6.33 | -0.16 % | $ 168 M | USA |
 |
IRIDEX Corporation
IRIX
|
52.7 M | $ 1.02 | -0.97 % | $ 17.3 M | USA |
 |
BioSig Technologies
BSGM
|
40 K | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
1.59 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
2.57 B | $ 296.51 | 1.46 % | $ 8.37 B | USA |
 |
Conformis
CFMS
|
62 M | - | - | $ 16.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
44.1 M | $ 3.38 | 2.43 % | $ 127 M |  France |
 |
Bruker Corporation
BRKR
|
3.37 B | $ 40.44 | 1.34 % | $ 6.03 K | USA |
 |
LENSAR
LNSR
|
58.4 M | $ 6.19 | 2.4 % | $ 74 M | USA |
 |
Boston Scientific Corporation
BSX
|
20.1 B | $ 64.61 | 1.24 % | $ 95.6 B | USA |
 |
Cytosorbents Corporation
CTSO
|
37.1 M | $ 0.6 | 1.26 % | $ 37.3 M | USA |
 |
Apollo Endosurgery
APEN
|
76.9 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
236 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
37 M | $ 10.54 | 1.54 % | $ 298 M | USA |
 |
Myomo
MYO
|
40.9 M | $ 0.8 | 0.39 % | $ 33.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
27.4 M | - | 14.99 % | $ 929 K | USA |
 |
Second Sight Medical Products
EYES
|
1 K | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
64 M | $ 25.75 | 2.14 % | $ 218 M | USA |
 |
CryoLife, Inc.
CRY
|
253 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
1.02 M | $ 2.85 | 1.61 % | $ 7.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
3.05 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
41 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
62.5 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
2.55 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
2.94 B | $ 94.84 | -0.11 % | $ 12.8 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
236 M | $ 18.41 | 3.05 % | $ 432 M | USA |
 |
Butterfly Network
BFLY
|
82.1 M | $ 4.76 | 7.09 % | $ 1.01 B | USA |
 |
Intersect ENT, Inc.
XENT
|
80.6 M | - | - | $ 955 M | USA |
 |
Tactile Systems Technology
TCMD
|
330 M | $ 25.59 | 2.11 % | $ 585 M | USA |
 |
BIOLASE
BIOL
|
49.2 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
85.2 M | $ 10.96 | 0.74 % | $ 393 M | USA |
 |
Tandem Diabetes Care
TNDM
|
290 M | $ 21.74 | 2.96 % | $ 1.48 B | USA |
 |
Inspire Medical Systems
INSP
|
912 M | $ 58.13 | 2.29 % | $ 1.71 B | USA |
 |
CONMED Corporation
CNMD
|
1.37 B | $ 39.54 | -0.48 % | $ 1.23 B | USA |
 |
LivaNova PLC
LIVN
|
1.39 B | $ 65.61 | 0.95 % | $ 3.58 B |  Britain |
 |
Integer Holdings Corporation
ITGR
|
1.85 B | $ 87.68 | -1.08 % | $ 3.05 B | USA |
 |
FONAR Corporation
FONR
|
97.6 M | $ 18.77 | 0.03 % | $ 123 M | USA |